Literature DB >> 3891604

Defective expression of HLA class I antigens: a case of the bare lymphocyte without immunodeficiency.

H Maeda, R Hirata, R F Chen, H Suzaki, S Kudoh, H Tohyama.   

Abstract

A case of the bare lymphocyte without apparent immunodeficiency was observed in a 33-year-old woman who had no history of severe infections but suffered from sino-bronchial disease. No HLA-A and -B antigens (class I antigens) were detected at the cell surface of lymphocytes, granulocytes, and platelets, but they were expressed, although at a reduced level, on the cultured B lymphoid cell line. T lymphocytes were normal in number and in the relative proportion of T4/T8 and responded to mitogens but not to PPD and candida. HLA-DR antigens (class II antigens) were present on B lymphocytes and showed intermediate MLR-stimulatory capacity, which made it possible to deduce the patient's HLA genotype. She was found to be homozygous at consanguinity for HLA-A, -B, and -DR antigens. The numbers of B lymphocytes, immunoglobulins, and complements were all in the normal range; there was, however, a low level of IgM. Two-dimensional gel analysis of class I antigens revealed the presence of normally expressed beta-2 microglobulins (B2M) and an apparently single set of class I heavy chains, allowing us to consider two alternative cellular mechanisms in this defect; the presence of one abnormal class I structural gene and the regulatory mechanism that acted in cis were suggested.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891604     DOI: 10.1007/bf00395879

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  13 in total

1.  Failure of lymphocyte-membrane HLA-A and -B expression in two siblings with combined immunodeficiency.

Authors:  R K Schuurman; J J van Rood; J M Vossen; P T Schellekens; T M Feltkamp-Vroom; E Doyer; F Gmelig-Meyling; H K Visser
Journal:  Clin Immunol Immunopathol       Date:  1979-12

2.  The bare-lymphocyte syndrome: report on the registry.

Authors:  J L Touraine
Journal:  Lancet       Date:  1981-02-07       Impact factor: 79.321

3.  Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.

Authors:  H Maeda; R Hirata; M Okuyama; A Thompson; H Tohyama
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

4.  Quantitative and qualitative differences in the distribution of HLA class I antigenic determinants in the human thymic compartments.

Authors:  C Müller; H Stein; A Ziegler; P Wernet
Journal:  Eur J Immunol       Date:  1983-05       Impact factor: 5.532

5.  Analysis of human class I antigens by two-dimensional gel electrophoresis. I. Polymorphism, evidence for additional (non-HLA-A, B, C) gene products, and identification of variant HLA-A, B antigens.

Authors:  R G Vasilov; A Hahn; H Mölders; J J van Rood; M Breuning; H L Ploegh
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  Combined immunodeficiency disease associated with absence of cell-surface HLA-A and -B antigens.

Authors:  J L Touraine; H Betuel; G Souillet; M Jeune
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

7.  HLA restriction of cell-mediated lysis of influenza virus-infected human cells.

Authors:  A J McMichael; A Ting; H J Zweerink; B A Askonas
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

8.  "Bare lymphocytes" without immunodeficiency.

Authors:  R Payne; F M Brodsky; B M Peterlin; L M Young
Journal:  Hum Immunol       Date:  1983-04       Impact factor: 2.850

9.  A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody.

Authors:  A J McMichael; J R Pilch; G Galfré; D Y Mason; J W Fabre; C Milstein
Journal:  Eur J Immunol       Date:  1979-03       Impact factor: 5.532

10.  Human cytotoxic T cell responses to trinitrophenyl hapten and influenza virus. Diversity of restriction antigens and specificity of HLA-linked genetic regulation.

Authors:  W E Biddison; S M Payne; G M Shearer; S Shaw
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

View more
  7 in total

1.  Immunodeficiency due to defective antigen processing: the molecular basis for type 1 bare lymphocyte syndrome.

Authors:  M Raghavan
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

Review 2.  TAP deficiency syndrome.

Authors:  S D Gadola; H T Moins-Teisserenc; J Trowsdale; W L Gross; V Cerundolo
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 3.  Immunity to microbes: lessons from primary immunodeficiencies.

Authors:  Magda Carneiro-Sampaio; Antonio Coutinho
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

4.  Bare lymphocyte syndrome--combined immunodeficiency and neutrophil dysfunction.

Authors:  N Will; R A Seger; C Betzler; G Dockter; N Graf; M Büttner; C Irlé; J M Tiercy; F C Sitzmann
Journal:  Eur J Pediatr       Date:  1990-07       Impact factor: 3.183

5.  HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1.

Authors:  H de la Salle; J Zimmer; D Fricker; C Angenieux; J P Cazenave; M Okubo; H Maeda; A Plebani; M M Tongio; A Dormoy; D Hanau
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

6.  Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome.

Authors:  H Furukawa; S Murata; T Yabe; N Shimbara; N Keicho; K Kashiwase; K Watanabe; Y Ishikawa; T Akaza; K Tadokoro; S Tohma; T Inoue; K Tokunaga; K Yamamoto; K Tanaka; T Juji
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

7.  Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency.

Authors:  Jacques Zimmer; Huguette Bausinger; Emmanuel Andrès; Lionel Donato; Daniel Hanau; François Hentges; Alessandro Moretta; Henri de la Salle
Journal:  PLoS One       Date:  2007-10-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.